⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight
globenewswire.com
INCY
ACRS
TAK
AZN
PFE
GSK
JNJ
NVS
SNY
BHC
REGN
ABBV
ALGN
BMY
AMGN
ARCT
CANF
Global Bispecific Antibody Market Intelligence & Growth Forecast to 2031: Opportunity, Dosage, Patents, Pricing, Sales, and Clinical Trials | Market to Top USD 60 Billion as 550+ Candidates Advance
globenewswire.com
JNJ
AMGN
ABBV
PFE
BMY
XNCR
ZYME
REGN
GILD
MRK
AZN
LULU
ROST
MDT
BIIB
VRTX
ALNY
CRSP
NTLA
EDIT
SRPT
NVO
SNY
LLY
TEVA
BHC
GNTX
Global Semi-Solid Dosage Drugs Market Size, Share and Trends, 2026-2033 | USD 14.16 Billion Opportunity Fueled by Topical Innovation, Aging Populations, and Online Pharmacy Growth
globenewswire.com
PFE
GSK
JNJ
VTRS
TEVA
BHC
SUN
SNY
Clinical Trial Supply and Logistics Market Forecast to Reach USD 8.58 Billion by 2034 as Biologics, Global Trials and Cold-Chain Requirements Reshape Supply Networks
globenewswire.com
CAT
AMZN
AMGN
BMY
CRIS
EXPE
FDX
GILD
IQV
LLY
MRK
NVS
PFE
REGN
SNY
TEVA
UPS
VRTX
Global Orphan Drugs Market Size, Share and Trends Analysis Report, 2026-2033 | Market to Reach USD 434.9 Billion as Gene and Cell Therapies Drive 9.0% CAGR
globenewswire.com
JNJ
AZN
NVS
VRTX
SNY
AMGN
MRK
BMY
PFE
Latent TB Diagnostics Market Report Now Available — Reveals Why Rising Prevalence and Rapid, Multiplex Testing Are Expanding Options Even as Cost Pressure Squeezes the Market
globenewswire.com
XRAY
DHX
QGEN
SNY
Immune Checkpoint Inhibitors Market Size, Share, Trends, and Global Forecast to 2030 | Next-Generation Targets and Combination Therapies Create New Growth Opportunities
globenewswire.com
BMY
GSK
INCY
NVS
JNJ
SNY
EXR
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
globenewswire.com
SNY
TEVA
Global Viral Vector and Plasmid DNA Manufacturing Market, 7th Edition: Forecast to 2035 | 9.73% CAGR Unlocks USD 2.16 Billion CMO and Gene Therapy Opportunity
globenewswire.com
CRL
CAT
TMO
NVS
BNTX
SNY
ISPE Names Sanofi S.A. the 2026 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Modulus Project
prnewswire.com
SNY